Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

GLP-1 agonists may increase the risk of hair loss.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

New cytokine-targeted therapies show promise for treating alopecia areata.

PDRN helps repair tissue and improve wound healing with a high safety profile.

Combining SVF cells with PRP may boost hair growth in androgenic alopecia.

Activin helps skin growth and healing mainly through stromal cells and affects keratinocytes based on its amount.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

New treatments for hair loss, including a compound called "ALRV5XR", platelet-rich plasma, and Adult Stem Cell-based therapy, are showing promise, but more trials are needed for confirmation.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Peptide-based PROTACs show promise in targeting hard-to-treat proteins, especially for cancer therapy.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Injectable platelet-rich fibrin helps hair growth by boosting key cell functions.

A new microneedle patch effectively promotes hair regrowth with less frequent dosing.

Combining PRP and microneedling effectively improves hair growth and patient satisfaction for hair loss.

PRP therapy may improve skin and hair conditions, but more research with standard methods is needed.

PRP therapy helps skin heal and improve by promoting cell growth and repair.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Bioengineered nanoparticles can effectively treat hair loss by targeting specific enzymes and receptors.

The new hydrogel speeds up wound healing by reducing inflammation and promoting tissue growth.

Platelet-rich Plasma Gel may help treat en coup de sabre scleroderma, improving symptoms and skin quality with minimal side effects.

Blocking Oncostatin M's role in the JAK-STAT pathway can stimulate hair growth in mice.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with less inflammation.

Platelet rich plasma is as effective as triamcinolone for treating alopecia areata.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Enhancing Tregs can protect against alopecia areata.